Childhood Epilepsy; Prognostic Factors in Predicting the Treatment Failure by TAGHDIRI, Mohammad Mehdi et al.
21Iran J Child Neurol. WINTER  2017  Vol 11 No 1
Mohammad Mehdi TAGHDIRI MD1,2, 
Mahmoud OMIDBEIGI MD 3, 
Sina ASAADI MD 4, 
Eznollah AZARGASHB 5,
Mohammad GHOFRANI MD 1,2
 
Revised: 30-Dec-2015
Last Revised: 18-May-2016  
Accepted: 11-June-2016 
1. Pediatric Neurology Research Center, 
Shahid Beheshti University of Medical 
Sciences, Tehran, Iran
2.  Pediatric Neurology Department, 
Mofid Children’s Hospital, Faculty of 
Medicine, Shahid Beheshti University 
of Medical Sciences, Tehran, Iran
3. Medical Student, Faculty of 
Medicine, Shahid Beheshti University 
of Medical Sciences, Tehran, Iran
4. General Practitioner, Functional 
Neurosurgery Research Center, Shahid 
Beheshti University of Medical 
Sciences, Tehran, Iran
5.  Department of Community 
Medicine, School of Medicine, Shahid 




Functional Neurosurgery Research 
Center, Shahid Beheshti University of 





We aimed to find the prognostic factors to detect the patients who fail the 
treatment of epilepsy, in the early stages of the disease.
Materials&Methods
This study was done on the epileptic patients attending the Neurology Clinic 
of Mofid Children’s Hospital, Tehran, Iran from September 2013 to October 
2014. After defining the criteria for exclusion and inclusion, the patients 
were divided to two groups based on responding to the medical treatment for 
their epilepsy and indices were recorded for all the patients to be used in the 
statistical analyses.
Results
The patients’ age ranged from 1 to 15 yr. There was 188 patients with refractory 
seizure in group 1 (experimental group) and 178 patient with well controlled 
seizure in group 2(control group).There was a significant different between 
serum drug level in both groups and patients with refractory seizure group 
had a lower serum drug level than control group. In both groups tonic-clonic 
was the most common type of seizure. Also the prevalence of brain imaging 
Abnormalityand other neurologic disorders was significantly higher in patients 
with refractory seizure in compare with control group.
Conclusion
Children with seizure who suffer from refractory epilepsy need more attention 
and exact observation by the medical staff.
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Introduction
Epilepsy is a neurological condition characterized by recurrent seizures without any 
known reason. “A large proportion of epilepsy begins in childhood and prevalence 
of epilepsy in children is approximately 3.5 to 7.2 per thousand children” (1). 
By the time being, analyzing distinctive aspects of epilepsy, including the risk 
of treatment failure and the risk of recurrent epilepsy remission is taken into 
consideration. Different types of seizures occur in children, and diagnosis is based 
on seizure type and its cause. The disease course varies from early remission after 
the onset of using the first drug to a permanent and uncontrollable seizure with 
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multiple drug failures.
Although, recuperation from seizures is more common 
in children than in adults, unfortunately, despite 
using various types of drugs, the first period of drug 
treatment fails in many cases and not all the children 
with seizures can be cured. Six to 41% of children with 
seizures do not respond to medical treatment due to 
refractory or uncontrolledepilepsy or drug resistance 
(2-7).Drug resistance is one of the major problems 
facing the treatment of epilepsy even with the new 
drugs and medical science progress. Treatment failure 
in childhood epilepsy has been left unexplained, of little 
evidence and the existing data have many challenging 
differences (8-10).
With regard to disability and mortality caused by 
refractory epilepsy, it is a big area of interest to assess 
the predictive factors of refractory epilepsy and to 
prevent the possible inability. Early diagnosis of 
refractory seizures helps to start treatment, including 
surgery or other interventions (11-13).Finding these 
predictive factors is important because the failure of the 
first treatment seems to be a factor of poor prognosis in 
responding to antiepileptic drugs (14-15).
In clinical practice, it is consequential for children 
to be diagnosed quickly and determined in terms of 
responding to medical treatment or failure. Predicting 
the group of children with high chance of responding 
to the medical treatment is important not only for the 
child and for the parents but also for the health system. 
Health system allows parents to make their choice 
about the allocation of appropriate treatment budget or 
if necessary, decide to use other treatment options (16-
20).
Few studies are designed to identify factors predicting 
treatment failure in patients with epilepsy and in some 
cases, conflicting factors are presented as influential; 
unfortunately, none of them is approved as a definite 
predictor of treatment failure (21-24).
So far, fewer studies are done to define uncontrolled 
epilepsy, drug resistance and the timing for refractory 
epilepsy to happen in children than in adults. There 
is also a little evidence on the cause of the high rate 
of treatment failure in childhood epilepsy. Even not 
a single definition of refractory childhood epilepsy is 
provided. Some research studies were conducted on 
refractory epilepsy, but many others considered limited 
factors and serum levels of the drug. Some studies had 
age limits, capable of restricting the results itself as 
well (25-28).
In this study, we intended to study epilepsy in children 
from birth to the age of 15 yr and factors affecting the 
patients with refractory epilepsy, like antiepileptic drug 
levels are compared in the control and treatment failure 
groups. 
Materials & Methods
This study was done on the epileptic patients attending 
the Neurology Clinic of Mofid Children’s Hospital, 
Tehran, Iran from September 2013 to April 2015. The 
study divided patients to two groups. The first group 
included patients who had epilepsy and responded 
well to the medical treatment (control group), and the 
second group patients were suffering from refractory 
epilepsy (subject group).
This study was approved by the Shahid Beheshti 
University of Medical Sciences Ethics Committee, 
and patients included in this study gave their informed 
consent to participate.
Exclusion and inclusion criteria
Exclusion criteria for the study were as follows: 
Involving in any underlying kind of absorption 
gastrointestinal disease, having febrile seizure, kidney 
or liver diseases or taking other drugs that interfere with 
antiepileptic drug absorption rate or its serum levels.
As an inclusion criterion after identifying and 
classifying patients according to the etiology of 
epilepsy, patients with idiopathic epilepsy (including 
simple seizure, atonic seizure, tonic-clonic seizure, 
absence seizure, complex seizure and tonic seizure) 
were chosen for the study. All clinical diagnosis was 
made by expert pediatric neurologist in our center. One 
group including patients received particular medical 
treatment and responded well to the treatment and the 
other group received the same treatment protocol but 
the seizure continued in accordance with the definition 
of refractory epilepsy.
After defining the groups, serum levels of antiepileptic 
drugs were measured. In both groups, drugs were of the 
same brand of a company. Levels of drug consumption 
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in patients were compared with statistical analysis 
between the control group and the examining group 
and the relationship between serum levels and risk of 
treatment failure is calculated. However, gender, age, 
family history of seizure, history of hospitalization in 
the neonatal period, age at onset, duration of epilepsy, 
seizure type, EEG pattern, disorders associated with 
anatomical imaging studies and any other underlying 
neurological disorders were recorded. Finally, according 
to the information obtained by the relationship between 
drug levels and other factors investigated, the risk of 
developing refractory seizures to the treatment and 
the need to increase the dose in this population were 
studied.
Routine measurement of serum levels of drugs was 
done during the treatment course so that the study 
would not be costly and time-consuming.
Study design
Three hundred ninety-nine patients were enrolled in 
this observational study and were followed up for at 
least 19 months up to 2 yr. Twenty-six of them were 
excluded because of drug revise in the study period. 
We identified refractory epilepsy as more than 1 seizure 
after>2 drug treatment for 18 months. Overall, 178 
patients of refractory epilepsy (case) and 188 patients 
of well-controlled epilepsy conforming to eligibility 
criteria were enrolled. The serum level of the drugs was 
recorded to determine which individual had reached 
the therapeutic level. In both case and control groups, 
numbers of males (95/178: 53.4%) were higher than 
females (114/188: 60.06%). This is for prevalence of 
seizure that is more common in males.
Data analysis
The SPSS software (version 19, SPSS Inc., Chicago, 
IL, USA) was used for statistical analysis. T-test and 
Chi-square test were used to evaluate which factors 
are more common in the refractory seizure group than 
control group. In this study P-value<0.05 was statically 
significant. 
Results
The patients’ age ranged from 1 to 15 yr; the patients 
‘mean age was 8.73 yr, with mean 8.17 yr in refractory 
group and 9.27 yr in controls. Results showed 
significant relationship between seizure in first year of 
life and resistance to AEDs (P= 0.002).
The diagnosed seizure types were simple (9.0%), 
atonic (21.3%), tonic-clonic (29.2%), absence (6.8%), 
complex (12.0%) and tonic (21.6%). As Figure 1 shows, 
there was a significant relationship(P= 0.000) between 
the type of seizure and contingency of refractory 
epilepsy in children. However, in both groups tonic-
clonic was the most common type but atonic (49/188: 
26.1%) in controls while tonic (36/178: 20.2%) were 
second incident types.
Risk factors and predictors
The present study determined the impression of 
independent predictors of refractory epilepsy such 
as; sex and age of patients, family history of seizure, 
type of seizure, abnormalities in EEG and imaging of 
the patients, other neurologic and metabolic disorders 
and serum drug level as a main predictor of refractory 
epilepsy. Table1 shows the comparison of refractory 
and well-controlled groups in measured prognostic 
factors.
Prevalence of refractory epilepsy was higher in patients 
with other concomitant neurological disorders (59/178: 
33.1%) compared to those without such disorders 
(12/188: 6.4%). 29.8% of patients of the resistant group 
had positive family history of seizure while those were 
22.3% in controls. Abnormal brain imaging was seen 
in 12.3% of all patients but24.7% of the patients in the 
refractory group had abnormalities in imaging that was 
significant (P=0.001).We classified EEG of the patients 
into three groups: normal, moderately abnormal and 
severely abnormal. We found no relationship between 
prevalence of every kind of EEGs and refractory 
epilepsy.
Another factor measured was serum level of the drug 
that patients were used. Table 2 shows the prevalence 
of epilepsy by serum drug level. Prevalence of “low 
serum drug level” was higher among individuals with 
refractory epilepsy [21.3%] compared to control group 
[3.7%], and this difference was statistically significant 
(P=0.031). 
This comparison represents “low serum level” as a 
predictor of refractory epilepsy. These variables also 
were factored for multivariate analysis. Data analysis 
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metabolic diseases in the patients we studied had the 
same prevalence in both groups.
In a study (11) aimed to investigate the treatment of 
children who failed the first period of drug therapy, 
90 children who had started their first medicine were 
studied and were followed for about 5 yr. Of the 
95 patients, 48 (50.5%) were known as idiopathic 
epilepsy, 30 (31.6%) as cryptogenic epilepsy and 17 
(17.9%) as symptomatic epilepsy. Two mostly used 
drugs to treat these patients were valproic acid (43.2%) 
and carbamazepine (38.9%). In 31.6% of the cases, 
treatment failed, in 40% of patients the failure happened 
due to the drug side effects, 37.9% was because of 
reduced efficacy of drugs and 24.1% of patients both 
these reasons (reduced drug efficacy and drug side 
effects) had made the results as such. Moreover, the 
age at diagnosis, drug selection, the highest drug dose, 
the etiology of epilepsy and epileptic syndromes were 
the factors considered in the study but no significant 
correlation was found between any of the factors 
mentioned and treatment failure with the first drug in 
children treated(11).
Electroencephalography does not seem to be able 
to predict the treatment failure because we did not 
observe a meaningful relationship between different 
EEGs and the treatment outcome, but some believe 
the abnormal EEG pattern can serve as a prognostic 
factor. A study (29) was done to investigate factors 
predicting drug resistance in children with epilepsy, in 
which 636 children were studied for 2 yr and criterion 
for resistance to treatment was continued epilepsy 
despite 18 months taking 2 drugs. There had been a 
significant relationship between the drug resistance 
and age, the number of seizures at the beginning of 
the disease, cause of the seizures, persistent seizures, 
seizures associated with fever in neonates, delayed 
mental and motor development, intermittent seizures 
in one day, abnormal EEG and/or MRI and specific 
epileptic syndromes. Among these factors the persistent 
seizures, abnormal EEG, and repeated seizures in a day 
can be introduced as predictive factors. Considering 
the results of different studies with different designs, 
brain imaging and taking a detailed history of other 
neurological diseases were recommended and with 
regard to unique featuresof electroencephalography 
based on multivariate analysis expresses concomitant 
neurological disorders, brain-imaging abnormalities, 
type of seizure and serum drug level as the most 
valuable predictors of resistant seizure in children.
Discussion
Refractory epilepsy has always been one of the 
challenges of treating this common disease, served 
as the topic for clinicians to find factors associated 
with this problem to treat patients or early diagnosis 
more accurately to help the patient, his family and 
the healthcare system. Most of the articles considered 
various factors in the patients treated with the first 
drug therapy period who had faced resistance (2,5,11).
Type of epilepsy is where less attention is paid. We 
considered that by dividing patients into different 
groups as mentioned in the results section. The current 
study showed there was a significant relationship 
between the type of epilepsy and resistance to the 
treatment (Figure 1).
The answer to the question of whether other patient’s 
neurological disorders is associated with refractory 
epilepsy is important because most patients do not 
suffer from such underlying disorders before the first 
seizures and therefore on the basis of high response rate 
to the treatment, they can be assure more than the other 
patients. Treatment failures in both sexes are equal but 
patients with abnormal brain imaging are more likely to 
face failure in the treatment plan. In addition, to these 
features related to the patient’s own characteristics, low 
levels of antiepileptic drug, as a separate indicator was 
studied, resistance to therapy in patients was evaluated 
and was higher in the examining group so that ‘low 
serum levels of antiepileptic drug’ can be introduced as 
a predictive factor for treatment failure.
We investigated the relationship between indicators 
and the prevalence of refractory epilepsy and as a 
result abnormal imaging and associated nervous 
disorders have the most significant role in interfering 
with the treatment plan, this finding recommends 
comprehensive studies on the relationship between the 
underlying disorder, its severity, patient presentations 
and other parameters able to help finding treatment-
resistant patients. Other medical problems do not seem 
to hinder directly treatment success, which is why 
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family to be aware of the condition. It is so important 
for the health system to evaluate the situation and 
reduce the burden of disease. There are factors able to 
predict whether a child will be facing treatment failure 
as low serum drugs level, other neurological disorders 
at the same time, positive family history and abnormal 
brain imaging. Better strategies are needed to control 
epilepsy and to reduce mental, social and financial 
pressures of refractory epilepsy on society, patients, 
families and healthcare systems.
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like being timesaving, availability, simplicity and 
reasonable cost, further studies with larger sample size 
are recommended. In another study (30), 495 patients 
were studied over 2 years. The aim of this study was 
to investigate whether the EEG epileptic form waves 
in patients can be used as prognostic factor of the 
effectiveness of the first line drug in patients or not. 
The results introduced the EEG epileptic form waves 
as an important predictive factor for the probability of 
first-line drug therapy failure, but regarding the findings 
obtained in our investigations, we cannot surely decide 
whether it is reasonable to trust the EEG patterns as a 
prognostic index or not.
Generally, factors indicating the intensity of the disease 
can be used as predictive factors when designing the 
study, in this case we used the type of epilepsy and 
associated neurological diseases but in a study (31) 
about 246 people as patients with refractory epilepsy 
(seizures at least once a month despite taking two anti-
seizure drugs) were monitored and the probability of 
seizure inactivation and its return in the population 
studied was investigated. Developmental retardation, 
refractory epilepsy duration and the number of 
drugs used in the failed therapeutic process have 
been suggested as negative factors predicting the 
inactivation of the seizure, applying these topics such 
as developmental retardation and the number of drugs 
used is an evidence to verify this fact.
Patients with seizure in their first year of life experienced 
treatment failure more, although no significant 
difference was observed between the mean age of the 
people studied in the groups but the patient’s age at 
diagnosis can act like a prognostic factor as a study (32) 
investigated the proportion of the drug therapy failure 
in childhood epilepsy in newly diagnosed children with 
epilepsy. In this study 225 patients were followed for 
about 4.2 yr. The results suggested approximately 32% 
of the patients failed the treatment with the first drug, 
as well as age at diagnosis, the cause of epilepsy and 
the type of drugs were introduced as factors associated 
with the failure of the first drug of choice.
In conclusion, some children with seizure who suffer 
from refractory epilepsy need more attention and 
exact observation by the medical staff. Regarding 
this prevalent condition, it is important for the patient 
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Low serum drug level 38[21.3] 7[3.7%] 0.031
Neurological findings 59[33.1] 12[6.4] 0.001
Positive family history 53[29.8] 42[22.3] 0.008
Abnormal brain imaging 44[24.7] 1[5] 0.001
Metabolic disorder 12[6.7] 14[7.4] 0.301
 Mean duration of seizure (min) 4.81 min 3.87 min 0.774
 
Fig 1: Frequency of each type of seizure in both groups
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